About 299,000,000 results
Open links in new tab
  1. Takeda Pharmaceuticals: Global Homepage

    Discover our balanced, diverse portfolio and strategy for sustainable, patient-centered and resilient growth. Fueled by our inherent curiosity, we translate science into highly innovative, …

  2. Takeda Pharmaceutical Company - Wikipedia

    The Takeda Pharmaceutical Company Limited[1] (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical …

  3. Takeda and Halozyme sign global agreement for Enhanze …

    3 days ago · Takeda has announced a global collaboration and licence agreement with Halozyme to continue advancing vedolizumab with the latter’s Enhanze drug delivery technology. …

  4. Takeda, XOMA ink new royalty agreement (TAK:NYSE)

    Dec 30, 2025 · XOMA Royalty (XOMA) and Takeda (TAK) stock in focus as the companies ink a new royalty deal and armed an existing agreement. Read more here.

  5. Takealot.com: Online Shopping | SA's leading online store

    South Africa's leading online store. Fast, reliable delivery to your door. Many ways to pay. Shop anything you can imagine: TVs, laptops, cellphones, kitchen appliances, toys, books, beauty & …

  6. Takea | Definition & Meaning - Merriam-Webster

    TAKEA is contained in 58 matches in Merriam-Webster Dictionary. Learn definitions, uses, and phrases with takea.

  7. Halozyme Announces Global Collaboration and License …

    4 days ago · /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced the Company entered into a global collaboration and exclusive license agreement with...

  8. Takeda, Protagonist seek FDA approval for rusfertide to treat PV

    Jan 6, 2026 · Takeda and Protagonist Therapeutics have jointly submitted a new drug application (NDA) seeking approval from the US Food and Drug Administration (FDA) for rusfertide to …

  9. 5 FDA drug approvals to watch in 2026 | PharmaVoice

    6 days ago · 5 FDA drug approvals to watch in 2026 Potential blockbusters and root-cause treatments from Eli Lilly, Merck, Takeda and others could get a regulatory nod this year.

  10. United States | Home - Takeda

    Apr 30, 2025 · Welcome to Takeda in the U.S. We’re the largest life sciences employer in the state of Massachusetts with our global hub and research center in Cambridge, MA., and have …